Protea to Present at the BIO CEO & Investor Conference in New York City February 8 at 8:30 AM ET

MORGANTOWN, W. Va., Feb. 02, 2016 -- Protea Biosciences Group, Inc., (OTCQB:PRGB) announced that the Company will be presenting at the BIO CEO & Investor Conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City. Stephen Turner, Chairman and CEO, will present at 8:30 am ET on Monday, February 8, 2016. 

To listen to the live audio webcast of the presentation during the event, please visit:

http://www.veracast.com/webcasts/bio/ceoinvestor2016/34103292263.cfm

A replay of the webcast will be available for 90 days after the initial presentation.

Management will be available for one-on-one meetings with conference attendees. Meetings can be arranged through the conference's partnering system at http://www.bio.org/events/conferences/bio-ceo-investor-conference or by contacting the Company at [email protected].

About Protea Biosciences

Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bio-analytical technology to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's proprietary technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.

For more Information:      
Protea Biosciences Group, Inc., 1311 Pineview Dr., Morgantown, WV 26505 USA
Phone:  304.292.2226                    Fax:  304.606.3049

https://proteabio.com/investors

[email protected]

Protea is a registered trademark of Protea Biosciences Group, Inc.